Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersen

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1068-1069. doi: 10.1136/jnnp-2018-320033. Epub 2019 Jan 10.

Authors

Benedikt Winter¹, René Guenther², Albert Christian Ludolph³, Andreas Hermann², Markus Otto³, Claudia Diana Wurster⁴

Affiliations

¹ Department of Pediatrics, Ulm University, Ulm, Germany.
² Department of Neurology, Technische Universität Dresden and German Center for Neurodegenerative Diseases, Research Side Dresden, Dresden, Germany.
³ Department of Neurology, Ulm University, Ulm, Germany.
⁴ Department of Neurology, Ulm University, Ulm, Germany claudia.wurster@uni-ulm.de.

PMID: 30630960
DOI: 10.1136/jnnp-2018-320033

No abstract available

Keywords: CSF; neuromuscular.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers / cerebrospinal fluid
Female
Humans
Infant
Neurofilament Proteins / cerebrospinal fluid*
Oligonucleotides / therapeutic use*
Spinal Muscular Atrophies of Childhood / cerebrospinal fluid*
Spinal Muscular Atrophies of Childhood / drug therapy
Treatment Outcome
tau Proteins / cerebrospinal fluid*

Substances

Biomarkers
Neurofilament Proteins
Oligonucleotides
neurofilament protein L
tau Proteins
neurofilament protein H
nusinersen